Search the Newsreel

IBD 50 Stocks To Watch: Obesity Drug Giant Eli Lilly Offers New Buy Point

Obesity-drug giant Eli Lilly stock is approaching a new buy point as the ongoing stock market rally strengthens. Continue Reading

Holly Futures Board to Review Interim Results and Consider Dividend

Wedge Capital Management L L P NC Sells 41,056 Shares of Ally Financial Inc. $ALLY

Wedge Capital Management L L P NC reduced its stake in Ally Financial Inc. by 4.8% in the second quarter, selling 41,056 shares and now owning 820,960 shares valued at approximately $37.7 million. Despite this, other institutional investors have increased their holdings, and Ally …

Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide

Eli Lilly has filed six lawsuits against U.S. companies for allegedly selling black-market versions of its experimental obesity drug, retatrutide, which is still in Phase 3 clinical trials and has not yet received regulatory approval. The company is targeting compounding pharmacies, medical spas, and …

Eli Lilly takes aim at illicit market for its experimental weight-loss drug

Eli Lilly is suing six companies for selling unapproved versions of its experimental weight-loss drug, retatrutide, in an effort to curb a growing illicit market. Despite the drug still being in clinical trials, promising results have led to widespread unauthorized sales by telehealth firms, …

Eli Lilly sues vendors accused of hawking versions of its experimental GLP-1

Eli Lilly has filed six lawsuits against wellness vendors, accusing them of illegally selling versions of its experimental weight-loss drug, retatrutide. The company aims to combat the illicit online sales of what it describes as a potent experimental GLP-1 drug. This action comes amidst …

Lilly files six lawsuits to crack down on black market retatrutide weight-loss shots

[Lilly Biotechnology Center in San Diego, California, USA.] JHVEPhoto Lilly escalated its fight against black-market retatrutide by filing six new lawsuits against U.S. sellers, including compounding pharmacies, medical spas, and online vendors, the drugmaker said Wednesday in a statement [https://seekingalpha.com/pr/20616057-lilly-calls-on-online-platforms-payment-companies-and-regulators-to-shut-down-the-illegal]. The company said retatrutide …

Ally Financial Inc. $ALLY Shares Sold by Royal Bank of Canada

Royal Bank of Canada reduced its stake in Ally Financial Inc. by 33.9% in the first quarter, selling over 82,000 shares but still retaining a significant holding valued at $6.3 million. Despite this, institutional investors and hedge funds own a substantial 88.76% of Ally's …

Annex Advisory Services LLC Has $39.02 Million Stake in O'Reilly Automotive, Inc. $ORLY

Annex Advisory Services LLC slightly reduced its stake in O'Reilly Automotive, Inc. by 2.6% in the second quarter, now holding shares worth $39.02 million. Meanwhile, several other major institutional investors significantly increased their positions in ORLY. The stock maintains a "Moderate Buy" rating from …

Transcript : Kelly Partners Group Holdings Limited, 2026 Earnings Call, Aug 12, 2026

Kelly Partners Group Holdings (ASX:KPG): FY26 Growth, Expansion and Business Outlook

Ally Financial Inc (ALLY) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Ally Financial Inc (ALLY), highlighting its current earnings forecast score of 7.89 and an average price target of $46.00. Based on analysis from 18 analysts, the stock receives a "Buy" rating. Key financial metrics such as expected …

Earnings call transcript: Kelly Partners Group posts strong H2 2026 growth

Ballymore Resources (ASX:BMR) Expands North Queensland Exploration Optionality

Kelly Partners Group Lifts Revenue 18% as International Expansion Continues

O'Reilly Automotive (ORLY) Announces $1.6 Billion Senior Notes Offering

O'Reilly Automotive (ORLY) has announced a $1.6 billion senior notes offering, comprising three tranches due in 2029, 2031, and 2037. The auto parts retailer intends to use the net proceeds, estimated at $1.59 billion, primarily to refinance its commercial paper program and for general …

Kelly Partners Group (ASX: KPG) Reports 18% FY26 Revenue Growth, Global Accounting Network Expands

Form 8K O’Reilly Automotive Inc For: 11 August By Investing.com

This article announces that O’Reilly Automotive Inc. filed a Form 8K on August 11. The article itself is very brief, serving mainly as a headline and placeholder on the Investing.com platform, alongside various market data and news summaries. It notes the stock symbol ORLY …

Eli Lilly Scores Major Win in Weight-Loss Drug Race

This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY) has secured U.K. approval for its once-daily weight-loss pill Foundayo, giving the drugmaker its first regulatory win for the treatment outside the U.S. and escalating its obesity battle with Novo Nordisk. The approval expands Lilly's …

Investors Buy Large Volume of Call Options on Ally Financial (NYSE:ALLY)

Investors recently showed significant interest in Ally Financial (NYSE:ALLY) call options, with trading volume surging over 1,000% above daily averages. This activity comes as Ally Financial maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $53.64. The company reported …

Eli Lilly Soars Past US$1 Trillion as Novo Nordisk Stumbles

Eli Lilly's valuation has exceeded US$1 trillion, driven by strong sales of its GLP-1 weight-loss and diabetes treatments, Mounjaro and Zepbound. In contrast, Novo Nordisk's shares have declined due to slowing US sales and a high reliance on a single therapeutic category, despite both …

Will Ulta Beauty's Omnichannel Edge Help Sustain Business Growth?

Ulta Beauty, Inc.'s ULTA omnichannel model remains an important part of its customer proposition, supported by the company's diverse assortment, digital convenience and loyalty program. In the first quarter of fiscal 2026, the company delivered 5.3% comparable sales growth, with broad-based performance as all …

Lilly Takes Its Weight-Loss Pill Battle Overseas

This article first appeared on GuruFocus. Eli Lilly and Co. (LLY, Financials), the developer of Foundayo and Zepbound, has received U.K. approval for Foundayo, the first approval for the weight-loss medication outside of the U.S. The The strategy pits Lilly directly against Novo Nordisk's …

Sally Beauty at canaccord growth conference: growth bets widen

Sally Beauty Holdings Inc. (SBH) presented at Canaccord Genuity’s 46th Annual Growth Conference, emphasizing its continued growth, cash generation, and reliance on hair color as a core strength. The company highlighted new initiatives to broaden its market reach, including expansion into fragrance, men's products, …

Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?

The duopoly dominating the multi-billion-dollar GLP-1 weight-loss market has moved from pharmacy shelves to the federal courtroom. Novo Nordisk A/S (NYSE:NVO) filed a lawsuit in U.S. District Court in New Jersey against Eli Lilly and Company (NYSE:LLY) on July 21, accusing its primary rival …

Veeva Vault CRM Selected by Eli Lilly and Company

Veeva Systems announced that Eli Lilly and Company (Lilly) has committed to using Veeva Vault CRM globally. This platform is part of the Vault CRM Suite, which supports an "agentic commercial" model leveraging AI to deliver medicines to more patients. Both companies expressed excitement …

Eli Lilly Commits to Veeva CRM to Bring More Medicines to Patients

Veeva Systems announced that Eli Lilly and Company will deploy Veeva Vault CRM globally. This commitment expands their strategic relationship, utilizing Veeva's AI-enabled "agentic commercial" model to help bring new medicines to more patients. The announcement highlights the continued adoption of Veeva's cloud solutions …

Eli Lilly and Company $LLY Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB reduced its stake in Eli Lilly and Company (NYSE:LLY) by 3.9% in the second quarter, selling 27,617 shares. Despite this sale, Eli Lilly remains a significant holding for Handelsbanken Fonder AB, representing 2.3% of its portfolio. Other institutional investors, however, increased …

O’Reilly Auto Parts Series TV Ratings: Iowa Speedway

The CW drew 1,017,000 total viewers for the recent HyVee Perks 250 O’Reilly Auto Parts Series race at Iowa Speedway, marking the most-watched Iowa race since 2018. This audience figure represents a 1% increase from last year's race, with viewership peaking at 1,258,000 total …

Bally’s Corporation (BALY) seeks Rule 12b-25 extension for June 2026 10-Q

Bally's Corporation has filed a Notification of Late Filing (Form NT 10-Q) for its Quarterly Report for the period ended June 30, 2026. The company stated it needs additional time to complete the review of its financial statements. Bally's expects to file the report …

Eli Lilly's Foundayo Wins UK Approval

(RTTNews) - Eli Lilly and Company's (LLY) oral GLP-1 pill Foundayo has secured UK regulatory approval for weight management and type 2 diabetes, making the UK the first European country to clear the once-daily tablet. The decision by the Medicines and Healthcare products Regulatory …

O'Reilly Automotive Inc (ORLY) Earnings Forecast: Future EPS & Revenue Growth Estimates

Projeções de Resultados: O'Reilly Automotive Inc (ORLY) — LPA e Crescimento de Receita

Historical marker dedicated in downtown Indy commemorating Eli Lilly and Company's founding

A historical marker has been dedicated in downtown Indianapolis to commemorate the founding of Eli Lilly and Company. The marker signifies the pharmaceutical giant's origins in the city.

Sally Beauty (SBH) Q3 2026 Earnings Call Transcript

Eli Lilly (LLY) Stock Gets Fair Value Bump After GLP 1 Driven Analyst Revisions

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Eli Lilly's updated fair value price target has shifted from US$1,270.37 to US$1,297.31, giving investors a fresh reference point for how analysts are framing the …